PetMed Express, Inc.
PetMed Express, Inc. (PETS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
pets · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Pharmaceuticals · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
PetMed Express, Inc.You PETS | $36M | N/A | — | — |
 Biodesix, Inc. BDSX | $125M | N/A | — | -$4.67 |
 Cytosorbents Corporation CTSO | $27M | N/A | — | -$0.13 |
 Fortress Biotech, Inc. FBIO | $97M | 14.98x | — | $0.24 |
 Genenta Science S.p.A. GNTA | $35M | N/A | — | -$0.32 |
 IceCure Medical Ltd ICCM | $8M | N/A | — | -$7.10 |
 Spectral AI, Inc. MDAI | $61M | N/A | — | -$0.29 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for PetMed Express, Inc. (PETS) measures how much investors pay for each dollar of the company's trailing earnings. PETS's current PE ratio of N/A is calculated by dividing its stock price of $1.70 by its TTM earnings per share of —.
Frequently asked questions
PETS pe ratio · 6 questionsPETS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.70 and TTM EPS of —. Data sourced from Financial Modeling Prep via PETS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · PetMed Express, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09